Bleomycin Pulmonary Toxicity in Adult Saudi Patients with Hodgkin's Lymphoma

被引:0
|
作者
Al-Mansour, Mubarak M. [1 ]
Al-Jizani, Wafa A. [1 ]
Al-Fayea, Turki [1 ]
Ruaa, Shafi [1 ]
Kazkaz, Ghieth A. [2 ]
Bayer, Ali M. [2 ]
AL-Foheidi, Meteb [1 ]
Ibrahim, Ezzeldin M. [2 ]
机构
[1] King Abdulaziz Med Ciity, Princess Norah Oncol Ctr, Jeddah, Saudi Arabia
[2] Int Med Ctr, Oncol Ctr Excellence, Jeddah, Saudi Arabia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma
    Al-Jizani, Wafa'a A.
    Al-Mansour, Mubarak M.
    Al-Fayea, Turki M.
    Shafi, Ruaa U.
    Kazkaz, Ghieth A.
    Bayer, Ali M.
    Al-Foheidi, Meteb E.
    Ibrahim, Ezzeldin M.
    FUTURE ONCOLOGY, 2015, 11 (15) : 2149 - 2157
  • [2] Bleomycin in Hodgkin's Lymphoma - A Boon or a Bane? - A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma
    Udupa, Chethana Babu K.
    Koteshwar, Prakashini
    Udupa, Karthik S.
    INDIAN JOURNAL OF PALLIATIVE CARE, 2019, 25 (04) : 523 - 526
  • [3] Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma
    Martin, WG
    Ristow, KM
    Habermann, TM
    Colgan, JP
    Witzig, TE
    Ansell, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) : 7614 - 7620
  • [4] Pulmonary toxicity induced by bleomycin in a patient with Hodgkin lymphoma
    CF Oliveira
    GA Costa
    DSF Oliveira
    EJ Troster
    FAC Vaz
    Critical Care, 9 (Suppl 2):
  • [5] Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma
    Sun, Haowei
    Atenafu, Eshetu G.
    Tsang, Richard
    Kukreti, Vishal
    Marras, Theodore K.
    Crump, Michael
    Kuruvilla, John
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2607 - 2614
  • [6] Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity
    Andersen, Maja Dam
    Wolter, Katharina
    Enemark, Marie Hairing
    Lauridsen, Kristina Lystlund
    Hamilton-Dutoit, Stephen Jacques
    Starklint, Jorn
    d'Amore, Francesco
    Ludvigsen, Maja
    Honore, Bent
    Kamper, Peter
    LEUKEMIA & LYMPHOMA, 2024,
  • [7] Pegfilgrastim Use and Risk of Bleomycin Induced Pulmonary Toxicity in Hodgkin Lymphoma
    Yao, David
    Janakiram, Murali
    O'Brien, Timothy E.
    BLOOD, 2016, 128 (22)
  • [8] Bleomycin pulmonary toxicity in Hodgkin's lymphoma treated with ABVD regimen not followed by radiation.
    Rajendran, Tara
    Prasad, Krishna
    CLINICAL CANCER RESEARCH, 2017, 23 (24) : 56 - 57
  • [9] Incidence and Predictors of Bleomycin Pulmonary Toxicity in Hodgkin Lymphoma (HL) Patients Treated with Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD)
    Sun, Haowei
    Atenafu, Eshetu
    Tsang, Richard
    Kukreti, Vishal
    Crump, Michael
    Kuruvilla, John
    BLOOD, 2011, 118 (21) : 1556 - 1556
  • [10] Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity
    Jona, Adam
    Miltenyi, Zsofia
    Ujj, Zsofia
    Garai, Ildiko
    Szilasi, Maria
    Illes, Arpad
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (10) : 1291 - 1297